Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T36557 | Target Info | |||
Target Name | Peroxisome proliferator-activated receptor delta (PPARD) | ||||
Synonyms | Peroxisomeproliferator-activated receptor beta; Peroxisomeproliferator activated receptor beta/delta; Peroxisome proliferator-activated receptor beta; PPARdelta; PPARB; PPAR-delta; PPAR-beta; Nuclear receptor subfamily 1 group C member 2; Nuclear hormone receptor 1; NUCI; NUC1; NR1C2 | ||||
Target Type | Clinical trial Target | ||||
Gene Name | PPARD | ||||
Biochemical Class | Nuclear hormone receptor | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | trans-Vaccenic acid | Ligand Info | |||
Canonical SMILES | CCCCCCC=CCCCCCCCCCC(=O)O | ||||
InChI | 1S/C18H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h7-8H,2-6,9-17H2,1H3,(H,19,20)/b8-7+ | ||||
InChIKey | UWHZIFQPPBDJPM-BQYQJAHWSA-N | ||||
PubChem Compound ID | 5281127 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 2B50 Human Nuclear Receptor-Ligand Complex 2 | ||||||
Method | X-ray diffraction | Resolution | 2.00 Å | Mutation | No | [1] |
PDB Sequence |
LKAFSKHIYN
220 AYLKNFNMTK230 KKARSILTGK240 ASHTAPFVIH250 DIETLWQAEK260 GLVWKLPPYK 275 EISVHVFYRC285 QCTTVETVRE295 LTEFAKSIPS305 FSSLFLNDQV315 TLLKYGVHEA 325 IFAMLASIVN335 KDGLLVANGS345 GFVTREFLRS355 LRKPFSDIIE365 PKFEFAVKFN 375 ALELDDSDLA385 LFIAAIILCG395 DRPGLMNVPR405 VEAIQDTILR415 ALEFHLQANH 425 PDAQQLFPKL435 LQKMADLRQL445 VTEHAQMMQR455 IKKTETETSL465 HPLLQEIYKD 475 M
|
|||||
|
ILE249
4.774
LEU255
3.755
TRP264
3.811
VAL281
3.955
PHE282
3.966
ARG284
3.820
CYS285
3.500
GLN286
4.009
THR288
4.062
THR289
2.703
HIS323
3.020
ILE326
4.593
|
|||||
PDB ID: 2AWH Human Nuclear Receptor-Ligand Complex 1 | ||||||
Method | X-ray diffraction | Resolution | 2.00 Å | Mutation | No | [1] |
PDB Sequence |
DLKAFSKHIY
219 NAYLKNFNMT229 KKKARSILTH243 TAPFVIHDIE253 TLWQAEKGLV263 WKEISVHVFY 283 RCQCTTVETV293 RELTEFAKSI303 PSFSSLFLND313 QVTLLKYGVH323 EAIFAMLASI 333 VNKDGLLVAN343 GSGFVTREFL353 RSLRKPFSDI363 IEPKFEFAVK373 FNALELDDSD 383 LALFIAAIIL393 CGDRPGLMNV403 PRVEAIQDTI413 LRALEFHLQA423 NHPDAQQLFP 433 KLLQKMADLR443 QLVTEHAQMM453 QRIKKTETET463 SLHPLLQEIY473 KDMY |
|||||
|
LEU255
4.367
TRP264
4.208
VAL281
3.929
PHE282
4.177
ARG284
3.754
CYS285
4.021
GLN286
3.800
THR288
3.630
THR289
2.449
HIS323
2.786
PHE327
4.010
LEU330
4.181
|
|||||
PDB ID: 2BAW Human Nuclear Receptor-Ligand Complex 1 | ||||||
Method | X-ray diffraction | Resolution | 2.30 Å | Mutation | No | [2] |
PDB Sequence |
LKAFSKHIYN
220 AYLKNFNMTK230 KKARSILTKA241 PFVIHDIETL255 WQAEKGLVWK275 EISVHVFYRC 285 QCTTVETVRE295 LTEFAKSIPS305 FSSLFLNDQV315 TLLKYGVHEA325 IFAMLASIVN 335 KDGLLVANGS345 GFVTREFLRS355 LRKPFSDIIE365 PKFEFAVKFN375 ALELDDSDLA 385 LFIAAIILCG395 DRPGLMNVPR405 VEAIQDTILR415 ALEFHLQANH425 PDAQQLFPKL 435 LQKMADLRQL445 VTEHAQMMQR455 IKKTETETSL465 HPLLQEIYKD475 |
|||||
|
LEU255
3.605
TRP264
3.723
VAL281
3.781
PHE282
4.382
ARG284
4.135
CYS285
3.487
GLN286
3.961
THR288
3.725
THR289
2.747
HIS323
2.895
PHE327
4.171
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Recombinant human PPAR-beta/delta ligand-binding domain is locked in an activated conformation by endogenous fatty acids. J Mol Biol. 2006 Mar 3;356(4):1005-13. | ||||
REF 2 | Reevaluation of the PPAR-beta/delta ligand binding domain model reveals why it exhibits the activated form. Mol Cell. 2006 Jan 6;21(1):1-2. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.